DSFIR Share Price Performance
€0
-100.75 (-100.00%)
Price €0
Fair Value€102.00
Share Pricen/a
DSM-Firmenich AG's (AMS:DSFIR) Shareholders Might Be Looking For Exit
Nov 26
DSM-Firmenich AG Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 43 Fair Values set on narratives written by author
DSFIR Community Narratives
AN
Fair Value €102 33.0% undervalued intrinsic discount
DSFIR: Resilient Consumer Health Demand Will Drive Performance Amid Pricing Pressure
0users have liked this narrative
0users have commented on this narrative
22users have followed this narrative
AN
Fair Value €71.89 5.0% undervalued intrinsic discount
Regulatory And Merger Challenges Will Constrain Benefits But Spark Growth
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Fair Value €146 53.2% undervalued intrinsic discount
Sustainability And Precision Nutrition Will Fuel Global Market Expansion
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
Regulatory And Merger Challenges Will Constrain Benefits But Spark Growth
Key Takeaways Increased regulatory pressures and supply chain complexities risk offsetting operational gains, potentially limiting margin expansion and profit growth despite sustainability-driven demand. Integration challenges, disruptive technologies, and intensified competition may cap revenue growth and undermine margins, even with ongoing innovation and higher-margin portfolio focus.Read more
23
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
€71.89
5.0% undervalued intrinsic discount
AnalystLowTarget's Fair Value
Revenue
0.56% p.a.
Profit Margin
5.16%
Future PE
32.81x
Price in 2028
€85.82
DSFIR: Resilient Consumer Health Demand Will Drive Performance Amid Pricing Pressure
Key Takeaways Focus on health-driven innovations, sustainability, and bio-based solutions enhances product differentiation, pricing power, and positions DSM-Firmenich for sustained organic growth. Integration synergies and increased exposure to local and regional customers boost margin improvements and revenue stability amid tightening sustainability regulations.Read more
149
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
22users have followed this narrative
AN
€102
33.0% undervalued intrinsic discount
AnalystConsensusTarget's Fair Value
Revenue
1.69% p.a.
Profit Margin
8.45%
Future PE
27.5x
Price in 2028
€121.71
Sustainability And Precision Nutrition Will Fuel Global Market Expansion
Key Takeaways Accelerated synergy realization and strategic divestitures are enhancing margins, unlocking capital, and positioning for faster, higher-quality earnings growth. Strong focus on sustainable, innovative solutions and local customer-driven expansion is driving above-market growth and expanding margins across global and emerging markets.Read more
10
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
€146
53.2% undervalued intrinsic discount
AnalystHighTarget's Fair Value
Revenue
4.72% p.a.
Profit Margin
9.33%
Future PE
32.25x
Price in 2028
€172.14
Trending Discussion
Recently Updated Narratives
AN
DSFIR Commoditization And Chinese Competition Will Shape Future Margin Resilience Narrative
Fair Value: €71.89 5.0% undervalued intrinsic discount
0 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
DSFIR: Market Share Defense Will Overcome Mounting European Competition Risks
Fair Value: €102 33.0% undervalued intrinsic discount
22 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Sustainability And Precision Nutrition Will Fuel Global Market Expansion
Fair Value: €146 53.2% undervalued intrinsic discount
0 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
DSM-Firmenich AG Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Feb 12, 2026
- 2.83
- 35.02%
- 5.52%
- 25.2%
About DSFIR
- Founded
- 1902
- Employees
- 28608
- CEO
- WebsiteView website
DSM-Firmenich AG provides nutrition, health, and beauty solutions in Switzerland, the Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia. The company operates through four segments: Perfumery & Beauty; Taste, Texture & Health; Health, Nutrition & Care; and Animal Nutrition & Health. The Perfumery & Beauty creates scents using natural, synthetic, and biotech ingredients. The Taste, Texture & Health segment provides food and beverages solutions, including flavors, natural extracts, and sugar reduction; and food enzymes, hydrocolloids, cultures, natural colorants, nutritional ingredients, and plant-based proteins. The Health, Nutrition & Care segment provides solutions for the early life nutrition, dietary supplement, pharmaceutical, medical nutrition, biomedical materials, and nutrition improvement markets. This segment also offers vitamins, nutritional lipids, minerals, carotenoids, botanical nutraceuticals, digestive enzymes, postbiotics, probiotics and prebiotics, and active pharmaceutical ingredients; biomedical solutions; and premix, market-ready, and personalized nutrition solutions, as well as expert services in regulatory affairs and nutrition. The Animal Nutrition & Health segment offers animal proteins, vitamins, performance solutions, and data-driven precision services. The company was founded in 1902 and is based in Kaiseraugst, Switzerland.
